SCHEMBL21743767

SCHEMBL21743767

c1cc2c(c(N3CCN4CCCC4C3)c1)CCNC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 4/20 0.48
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
CHRM5 P08912 1/20 0.48
CHRM1 P11229 1/20 0.48
CHRM3 P20309 1/20 0.48
TLR9 Q9NR96 3/20 0.46
TLR7 Q9NYK1 3/20 0.46
CD44 P16070 1/20 0.40
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
HTR6 P50406 2/20 0.39
HRH3 Q9Y5N1 2/20 0.38
HTR2C P28335 4/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
HTR2B P41595 1/20 0.36
TLR8 Q9NR97 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21744701 1.00 CXCR4 (0.48) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL21743762 0.86 CD44 (0.45) CXCR4TLR9TLR7CD44DRD2
SCHEMBL21743758 0.80 CXCR4 (0.46) CXCR4TLR9TLR7CD44DRD2
SCHEMBL21744413 0.79 TLR9 (0.44) TLR9TLR7CD44HTR6HTR2C
SCHEMBL21743769 0.79 DRD2 (0.45) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL16485203 0.74 CD44 (0.50) TLR9TLR7CD44DRD2DRD3
SCHEMBL24975339 0.74 CXCR4 (0.60) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL21744394 0.74 HTR2C (0.54) CD44DRD2DRD3HTR6HTR2C
SCHEMBL21744248 0.74 CD44 (0.50) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL21744605 0.74 CD44 (0.46) CXCR4CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CXCR4 1/4885CHRM2 2559/4885CHRM4 2165/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CXCR4 1/4885CHRM2 2559/4885CHRM4 2165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.